德尔塔
您当前所在位置:首页 > 生命科学 > 全部产品

「同位素标记抑制剂」CAS:2315262-31-6|Psychosine-d7

发布时间:2025-06-13     作者:德尔塔生物   分享到:

【产品介绍】:

生物活性:Psychosine-d7 is deuterium labeled Psychosine. Psychosine, a substrate of the galactocerebrosidase (GALC) enzyme, is a potential biomarker for Krabbe disease. Psychosine is a highly cytotoxic lipid, capable of inducing cell death in a wide variety of cell
体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[3].
德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.
Psychosine-d7 相关抗体:
Phospho-PKC alpha (T638) Antibody
Phospho-PKC zeta (T560) Antibody
PKC alpha Antibody
PKC beta 1 Antibody
PKC beta 2 Antibody
PKC delta Antibody
PKC epsilon Antibody
PKC gamma Antibody
Ezrin Antibody (YA767)
PKC eta Antibody
SGK1 Antibody (YA1525)
PKC theta Antibody (YA3162)
Villin Antibody
Phospho-PKC alpha (Ser657) Antibody (YA1023)
Phospho-PKC alpha (Thr638) Antibody (YA1024)
PRKCQ Antibody (YA1106)
AMHR2 Antibody (YA1337)
Phospho-PKC (Ser660) Antibody (YA1394)
Phospho-PKC delta (Ser299) Antibody (YA2628)
Phospho-PKC zeta/lambda (Thr410/Thr412) Antibody (YA2631)
Phospho-PKC zeta (Thr560) Antibody (YA2679)
分子量:468.68
Formula:C24H40D7NO7
CAS 号:2315262-31-6
非标记 CAS:2238-90-6
中文名称:鞘氨醇半乳糖苷-d7;半乳糖基鞘氨醇-d7
运输条件:Room temperature in continental US; may vary elsewhere.
储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.
纯度 & 产品资料
Data Sheet (527 KB)
产品使用指南 (1538 KB)
参考文献
[1]. M L Escolar, et al. Psychosine, a marker of Krabbe phenotype and treatment effect. Mol Genet Metab. 2017 Jul;121(3):271-278.
 [Content Brief]
[2]. Jacqueline A Hawkins-Salsbury,et al.Psychosine, the cytotoxic sphingolipid that accumulates in globoid cell leukodystrophy, alters membrane architecture. J Lipid Res.2013 Dec;54(12):3303-11.
 [Content Brief]
[3]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223.
 [Content Brief]